ASBPAspire Biopharma Holdings Inc. Common Stock

7.970USD+0.89%Mkt Cap: 11.18M $P/E:

Aspire Biopharma Holdings, Inc., an early-stage biopharmaceutical company, develops and markets disruptive technology for novel sublingual delivery mechanisms in the United States. It offers sublingual aspirin product th…

Key Statistics

Company
Market Cap11.18M $
Enterprise Value-1.20M $
Revenue (TTM)97.66K $
Gross Profit-116 $
Net Income (TTM)-24.48M $
Revenue/Share0.2950 USD
Last Price7.970 USD
Fiscal Year EndDec 2025
MR QuarterJun 2026
Employees
CountryUS
SectorHealthcare
IndustryBiotechnology
ISIN
Valuation
P/E (Trailing)
P/E (Forward)
PEG
EV/EBITDA
EV/Revenue-12.28
P/S112.31
P/B0.86
EPS (TTM)-6.66
EPS (Forward)
52W Range
0.110023% of range35.00
52W High35.00 USD
52W Low0.1100 USD
Profitability
Gross Margin-1.87%
Oper. Margin-3880.58%
EBITDA Margin0.00%
Profit Margin-394725.06%
ROE383.93%
ROA-1865.68%
Growth
Revenue Growth
Earnings Growth
Cash Flow & Leverage
Operating CF-4.92M $
CapEx (TTM)
FCF Margin7609.32%
FCF Yield66.48%
Net Debt-12.17M $
Net Debt/EBITDA
Balance Sheet
Debt/Equity-0.81
Current Ratio7.99
Quick Ratio7.22
Book Value/Sh9.078 USD
Cash/Share8.675 USD
Dividends
Fwd Div Rate
Trail. Div Rate0.0000 USD
Div. Yield
5Y Avg Yield
Payout Ratio0.00%
Ex-Div Date
Pay Date
Splits
Last Split1:40
Split DateJan 16, 2026
Analyst Consensus
Rating
Target (Mean)
Target Range
# Analysts
Ownership
Shares Out.1.40M
Float1.09M
Insiders12.98%
Institutions3.36%
Short Interest
Short Ratio1.2d
Short % Float6.22%
Short % Out.6.17%
Shares Short79.92K
Short (prev mo.)101.41K
Technical
SMA 506.612 (+20.5%)
SMA 2003.919 (+103.4%)
Beta0.11
S&P 52W Chg18.16%
Avg Vol (30d)43.02K
Avg Vol (10d)30.64K
Technical Indicators
RSI (14)59.8
MACD0.3901
MACD Signal0.3586
MACD Hist.+0.0315
BB Upper8.361 USD
BB Middle7.248 USD
BB Lower6.134 USD
BB Width30.73%
ATR (14)0.6679 USD
Vol Ratio (20d)0.79x